Blog

Cannabis Rescheduling Reactions Mixed: While Some Applaud Potential, Others Push For More Executives, lawmakers and nonprofit leaders weigh in on the significance and shortcomings of the DEA's move to reclassify cannabis as a less dangerous substance.

Industry Reacts to Rescheduling News Prepared statements from industry members started flowing into our inboxes immediately after the news broke that the Drug Enforcement Agency (DEA) will soon begin rescheduling cannabis from Schedule 1 to… The post Industry Reacts to Rescheduling News appeared first on Cannabis Business Executive - Cannabis and Marijuana industry news.

DEA Moves To Reclassify Cannabis Under Schedule III in Historic Move, Report Indicates The DEA under the Biden administration finally proposed the process of moving cannabis to Schedule III. The post DEA Moves To Reclassify Cannabis Under Schedule III in Historic Move, Report Indicates first appeared on High Times.

US drug control agency will move to reclassify marijuana in a historic shift, AP sources say WASHINGTON (AP) — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, The Associated Press has learned, a historic shift to generations of American drug policy that could… The post US drug control agency will move to reclassify marijuana in a historic shift, AP sources say appeared first on Cannabis Business Executive - Cannabis and Marijuana industry news.

BREAKING: DEA Will Reschedule Cannabis The federal agency that has long enforced prohibition will align with the recommendation from the FDA to reclassify cannabis as a Schedule III substance under the Controlled Substances Act, according to The Associated Press sources.

AYR Wellness and Lake Erie College of Osteopathic Medicine Partner on Medical Research Studying ‘Quality of Life’ Benefits of Medical Cannabis The organizations published the results of the first of five studies and co-hosted a Pennsylvania Medical Marijuana Program Research Summit.

How to Improve Email Marketing Results for Cannabis Businesses By Susan Gunelius Email marketing is critical for every cannabis business since so many advertising channels are not accessible to businesses working in and with the cannabis industry. However, sending… The post How to Improve Email Marketing Results for Cannabis Businesses appeared first on Cannabis Business Executive - Cannabis and Marijuana industry news.

Psychedelic Research Proves Rather Tricky for the FDA Nasty claims of bias and impartial research stand in the way of MDMA gaining FDA clearance for PTSD. The post Psychedelic Research Proves Rather Tricky for the FDA first appeared on High Times.

Chronic Pot Use Has Minimal Effect on Motivation, Study Shows The debunking of the "lazy stoner" stereotype isn't breaking news, but sometimes it's nice to be reminded. This new study out of the University of Toronto is just that. The post Chronic Pot Use Has Minimal Effect on Motivation, Study Shows first appeared on High Times.

Psychedelic Drug Market Poised to Hit $4.6B by 2030 MarketDigits released predictions about the psychedelic drug sector showing ample growth. The post Psychedelic Drug Market Poised to Hit $4.6B by 2030 first appeared on High Times.